January 21, 2018 2:18 PM ET

Healthcare Equipment and Supplies

Company Overview of DxTerity Diagnostics Inc.

Company Overview

DxTerity Diagnostics Inc. is a molecular diagnostic company and clinical laboratory. Its DxDirect technology allows for quantitative analysis of genomic biomarkers from a single tube for measuring the progress and state of disease from a sample input. The company also provides DxDIRECT probes; DxDIRECT reagent kits that offer reagents for various reactions; and DxCOLLECT blood collection that offers blood collection, as well as provides stabilization of nucleic acids at ambient temperatures for storage and transportation. In addition, it offers testing services for rheumatoid arthritis. DxTerity Diagnostics Inc. was founded in 2006 and is based in Rancho Dominguez, California.

19500 South Rancho Way

Suite 116

Rancho Dominguez, CA 90220

United States

Founded in 2006

Phone:

310-537-7857

Fax:

310-356-3154

Key Executives for DxTerity Diagnostics Inc.

Founder, Chief Executive Officer and President
Co-Founder, Chief Financial Officer and Chief Operating Officer
Vice President of Regulatory and Quality
Vice President of Research & Development
Compensation as of Fiscal Year 2017.

DxTerity Diagnostics Inc. Key Developments

DxTerity Diagnostics Inc. Presents at 11th Annual Canaccord Genuity Medical Technology & Diagnostics Forum, Nov-09-2017 04:30 PM

DxTerity Diagnostics Inc. Presents at 11th Annual Canaccord Genuity Medical Technology & Diagnostics Forum, Nov-09-2017 04:30 PM. Venue: Westin New York Grand Central Hotel, 212 East 42nd Street, New York, New York, United States.

DxTerity Collaborates with City of Hope Medical Center on the Development of a Cancer Genomic Blood Test to Predict Response to Radiation Therapy

DxTerity announced that it is collaborating with the City of Hope Medical Center on the clinical development of a blood test that could possibly predict whether cancer patients about to undergo radiation therapy are likely to benefit from the treatment, as well as identify those who are at risk for radiation toxicity. This research program is being funded in part by the National Cancer Institute. Radiation therapy or radiotherapy plays an important role in the fight against cancer with more than 60% of all patients receiving some form of radiation treatment. Despite its excellent overall safety profile, approximately 10% of patients experience radiation toxicity, while some patients may not benefit from the treatment. To address this clinical need, DxTerity is developing a genomic blood test to identify which patients are most likely to benefit from radiation treatment thereby allowing oncologists to minimize radiation exposure for unresponsive and sensitive patients, or use adjunctive therapies, such as immunotherapy, to improve radiotherapy response.

Dxterity Diagnostics Inc. Wins $22,465,186 Federal Contract

DxTerity Diagnostics Inc., Rancho Dominguez, California, won a $22,465,186 federal contract from the U.S. Department of Health and Human Services for the validation and acquisition of a radiation biodosimetry high throughput test.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
NYC2012, Inc. United States
John F. Kennedy Center For The Performing Arts United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DxTerity Diagnostics Inc., please visit www.dxterity.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.